Mangalam Drugs & Organics, one of the leading Pharma/API Company has successfully completed the expansion/ modernization work of its Plant on Unit-2 situated at Vapi. The company has also commenced the trial operations at this newly expanded Unit-2 situated at Vapi on August 22, 2016. The company also takes pride in announcing that it has completed this project in record time. The total cost of the expansion is around Rs 30 crore.
The plant will produce the API's for Malaria and ARV's. The company will be filing DMF's for all its product with WHO Geneva. It also plans to file DMF's of certain API's with USFDA in the due course of time.
Mangalam Drugs & Organics is a part of the MangalamGroup, manufactures chemicals such as API perfumery, disperse dye intermediates, bulk drugs and bulk drugs intermediates at VAPI-Gujarat State. It has a multi-product manufacturing facility and a in-house Research and Development (R&D) Base.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: